ArticlePulmonary therapy2026

Real-World Outcomes in Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate After Dual and Triple Therapy in Spain: A Sub-Study of the ORESTES Study.

Juan Marco Figueira-Gonçalves et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.